|
시장보고서
상품코드
2008140
귀감염증 치료 시장 : 감염증별, 원인별, 유형별, 지역별Ear Infection Treatment Market, By Infection, By Cause, By Type, By Geography |
||||||
귀감염증 치료 시장은 2026년에 131억 4,950만 달러로 추정되고 있으며, 2033년까지 176억 860만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 6.5%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 131억 4,950만 달러 |
| 실적 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년의 예측 기간 CAGR : | 6.50% | 2033년 시장 규모 예측 : | 176억 860만 달러 |
귀에 감염이 생기면 중이에서 목 안쪽 상부로 이어지는 가는 관(이관)이 붓고 막힐 수 있습니다. 귀 감염은 귀의 내층, 중층, 외층 모두에 영향을 미칠 수 있습니다. 콧물이 며칠간 지속된 후 귀가 아프고 열이 난다면 귀에 감염된 것으로 의심해 볼 수 있습니다. 급성 중이염(AOM)은 가장 흔한 귀 감염 질환입니다. 이로 인해 일반적으로 '귀 통증'이라고 불리는 귀의 통증이 발생합니다. 급성 중이염은 심한 통증과 불편함을 유발하기도 합니다. 치료법은 다양하며 경과 관찰, 항생제, 항염증약 등이 포함됩니다. 대부분의 경우, 귀 감염은 자연적으로 치유됩니다.
시장 역학
성인에 비해 소아의 귀 감염 사례가 증가함에 따라 안전하고 효과적인 치료법에 대한 수요가 증가할 것으로 예상되며, 이는 예측 기간 중 글로벌 귀 감염 치료 시장의 성장을 촉진할 것으로 예상됩니다. 소아의 외이도는 성인에 비해 가늘고 수평에 가까운 모양을 하고 있습니다. 따라서 정상적인 상태에서도 귀에서 액체가 잘 배출되지 않습니다. 따라서 소아는 성인보다 귀 감염에 더 쉽게 걸리는 경향이 있습니다. 2021년 3월 발표된 보고서('급성 중이염')에 따르면 전체 소아의 약 80%가 일생에 한 번은 중이염을 경험하고, 전체 소아의 80-90%가 취학 전 삼출성 중이염을 앓는다고 합니다. 또한 미국 국립 청각 및 기타 의사소통 장애 연구소(National Institute on Deafness and Other Communication Disorders)가 2021년 3월에 발표한 기사에 따르면 미국 어린이 6명 중 5명이 3세까지 중이염을 앓고 있다고 합니다. 경험하고 있습니다.
본 조사의 주요 특징
- 이 보고서는 2021년을 기준연도로 하여 예측 기간(2022-2028년) 시장 규모와 CAGR %를 제시하는 글로벌 귀 감염 치료 시장에 대한 상세한 분석을 제공합니다.
- 이 보고서는 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트도 제공합니다.
- 이 보고서에서는 회사 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 세계의 귀 감염 치료 시장의 주요 기업 개요을 분석합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 귀 감염 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 귀감염증 치료 시장 : 감염증별, 2026-2033년
제5장 세계의 귀감염증 치료 시장 : 원인별, 2026-2033년
제6장 세계의 귀감염증 치료 시장 : 유형별, 2026-2033년
제7장 세계의 귀감염증 치료 시장 : 지역별, 2026-2033년
제8장 경쟁 구도
제9장 섹션
KSA 26.05.04Ear Infection Treatment Market is estimated to be valued at USD 13,149.5 Mn in 2026 and is expected to reach USD 17,608.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 13,149.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.50% | 2033 Value Projection: | USD 17,608.6 Mn |
In an ear infection, narrow tubes that run from the middle ear to high in the back of the throat (eustachian tubes) can become swollen and blocked. Ear infection can affect the inner, middle, and outer layer of the ear. Ear pain and new onset fever after several days of a runny nose is probably an ear infection. Acute otitis media (AOM) is the most common type of ear infection. This causes pain in the ear, commonly called an earache. Acute ear infections also cause severe pain and discomfort. Treatment varies and may include watchful waiting, antibiotics, and anti-inflammatory medicines. In many cases, ear infections clear up on their own.
Market Dynamics
Increase in demand for safe and effective treatment due to increase in cases of ear infections in children compared to adults is expected to propel growth of the global ear infection treatment market during the forecast period. Eustachian tubes are smaller and more level in children than they are in adults. This makes it difficult for fluid to drain out of the ear, even under the normal conditions. Thus, children are more prone to ear infections than adults. According to the report published in March 2021 (titled Acute Otitis Media), around 80% of all children experience a case of otitis media during their lifetime, and between 80% and 90% of all children will have otitis media with an effusion before school age. Moreover, according to an article published in March 2021 by the National Institute on Deafness and Other Communication Disorders, 5 out of 6 children in the United States experience ear infection by 3 years of age.
Key features of the study
- This report provides in-depth analysis of the global ear infection treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global ear infection treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Cipla Ltd., Johnson & Johnson, GlaxoSmithKline Plc, Sanofi SA, Grace Medical, Novartis AG, Pfizer Plc, Olympus Corporation, and American Diagnostic Corporation, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global ear infection treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ear infection treatment market.
Market Segmentation
- By Infection
- Inner Ear Infection
- Middle Ear Infection
- Outer Ear Infection
- By Cause
- Viral Infection
- Bacterial Infection
- By Type
- Medication
- Surgery
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- Cipla Ltd.
- Johnson & Johnson
- GlaxoSmithKline Plc
- Sanofi SA
- Grace Medical
- Novartis AG
- Pfizer Plc
- Olympus Corporation
- American Diagnostic Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Infection
- Market Snapshot, By Cause
- Market Snapshot, By Type
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter's Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
4. Global Ear Infection Treatment Market, By Infection, 2026 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
- Inner Ear Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Middle Ear Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Outer Ear Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
5. Global Ear Infection Treatment Market, By Cause, 2026 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Viral Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Bacterial Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
6. Global Ear Infection Treatment Market, By Type, 2026 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
7. Global Ear Infection Treatment Market, By Region, 2026 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cause, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cause, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cause, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cause, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cause, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Infection, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Cause, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
- Cipla Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- GlaxoSmithKline Plc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Sanofi SA
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Grace Medical
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Pfizer Plc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Olympus Corporation
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- American Diagnostic Corporation
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Analyst Views
9. Section
- References
- Research Methodology
- About Us
